Live Breaking News & Updates on Recursion Pharma|Page 5

Stay updated with breaking news from Recursion pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tapping Into AI ML Partnerships To Advance Drug Discovery With Recursion Pharma

"TechBio" company Recursion Pharma has entered agreements to acquire AI/ML company Cyclica for $40 million and Valence for $47.5 million. ....

Salt Lake City , United States , Yoshua Bengio , Najat Khan , Chris Gibson , Recursion Pharma , Bay Area , Scientific Advisor Yoshua Bengio ,

New Biotechnology Combines Targeted and Immune Therapies to Kill Treatment-resistant Cancer Cells

/PRNewswire/ Targeted therapies specifically attach to and hinder cancer-causing proteins, but cancer cells can quickly evolve to thwart their action. A. ....

United States , Navire Pharma , Revalia Bio , Padma Akkapeddi , Lorenzo Maso , Akiko Koide , James Hayman , Shohei Koide , Kiyomi Araki , Benjaming Neel , Takamitsu Hattori , Langone Health , Arvinas Inc , National Institutes Of Health , Department Of Biochemistry , American Association For Cancer Research , Puretech Health , Northern Biologics , Perlmutter Cancer Center , Molecular Pharmacology , Cancer Discovery , American Association , Cancer Research , Perlmutter Cancer , National Institutes , Perlmutter Cancer Center Support ,

New Biotechnology Combines Targeted and Immune Therapies to Kill Treatment-resistant Cancer Cells

NEW YORK, Oct. 17, 2022 /PRNewswire/ Targeted therapies specifically attach to and hinder cancer-causing proteins, but cancer cells can quickly. ....

United States , Navire Pharma , Gregory Williams , Revalia Bio , Padma Akkapeddi , Lorenzo Maso , Akiko Koide , James Hayman , Shohei Koide , Benjaming Neel , Kiyomi Araki , Takamitsu Hattori , Langone Health , Arvinas Inc , National Institutes Of Health , Department Of Biochemistry , American Association For Cancer Research , Grossman School Of Medicine , Puretech Health , Northern Biologics , Perlmutter Cancer Center , Molecular Pharmacology , Cancer Discovery , American Association , Cancer Research , Perlmutter Cancer ,

Model Suggests Surgery Should Come Before Chemotherapy for Select Patients with Aggressive Ovarian Cancer

Model Suggests Surgery Should Come Before Chemotherapy for Select Patients with Aggressive Ovarian Cancer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Barry Rosen , Gregory Williams , Shengqing Gu , Stephanie Lheureux , Marcus Bernardini , Azin Sayad , Benjaming Neel , Paulina Cybulska , Iryna Vyarvelska , Dongsheng Tu , Langone Health , Arvinas Inc , Northern Biologics Inc , Matthew Nankivell At University College London , University Of Toronto , Amit Oza At Princess Margaret Cancer Center , Grossman School Of Medicine , Jengu Therapeutics Inc , Ontario Ministry Of Health , Sean Kehoe At University Of Birmingham , Navire Pharmaceuticals , Mary Kay Foundation , York University , Princess Margaret Cancer Center , Dana Farber Cancer Institute ,

Prototype Shows Promise As Approach to Countering Pancreatic Cancer

Prototype Shows Promise As Approach to Countering Pancreatic Cancer
News provided by
Share this article
Share this article
NEW YORK, May 11, 2021 /PRNewswire/ A research team has designed a molecule with potential to interfere in a new way with altered proteins that cause abnormal growth in 35 percent of pancreatic cancers.
Published online in
Nature Communications on May 11, a new study found that a molecule called a monobody clings to cancer-causing versions of the KRAS protein and keeps them from transmitting their signals. Changes in the DNA of the
KRAS gene – which encodes a molecular switch that toggles between active and inactive states to regulate growth – cause the related protein to become stuck in the on mode. Cells with such mutations continually multiply and give rise to cancer. ....

United States , Carmine Fedele , Steven Tsai , Yingkai Zhang , Gregory Williams , Kai Wen Teng , John Obryan , Akiko Koide , Shohei Koide , Benjamin Neel , Xuben Hou , Takamitsu Hattori , National Institutes Of Health , Langone Health Perlmutter Cancer Center , Department Of Biochemistry , Department Of Cell , Langone Perlmutter Cancer Center , Nature Communications On , York University Application No , Grossman School Of Medicine , Puretech Health , Department Of Chemistry At New York University , Navire Pharmaceuticals , American Cancer Society , Perlmutter Cancer Center , Nature Communications ,